MGNX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.30%

Insider Buying (Last 12 Months): $669,000.00

Insider Selling (Last 12 Months): $1,626,689.93

MacroGenics Insider Trading History Chart

MacroGenics Share Price & Price History

^$3.43

▼ -0.27 (-7.30%)

As of 09/16/2024 01:00 AM ET

Days: 30 | 90 | 365

War on Elon Escalates…

From Porter & Company | Ad

Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

Click here to learn how you can benefit from its widespread distribution.

MacroGenics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/4/2024	Jeffrey Stuart Peters	VP	Sell	51,395	$15.55	$799,192.25
2/26/2024	Jeffrey Stuart Peters	VP	Sell	16,124	$17.22	$277,655.28	8,895
2/1/2024	Ezio Bonvini	SVP	Sell	13,316	$15.00	$199,740.00	74,668
1/19/2024	Ezio Bonvini	SVP	Sell	13,316	$12.00	$159,792.00	87,984
12/20/2023	Ezio Bonvini	SVP	Sell	18,880	$10.08	$190,310.40	101,300
10/2/2023	Target N V Biotech	Major Shareholder	Buy	150,000	$4.46	$669,000.00	9,929,963
9/7/2023	Target N V Biotech	Major Shareholder	Buy	200,000	$5.26	$1,052,000.00	9,779,963
8/30/2023	Edward Hurwitz	Director	Buy	15,000	$4.91	$73,650.00	33,074
3/10/2023	Jeffrey Stuart Peters	VP	Sell	5,372	$6.03	$32,393.16
2/14/2023	Target N V Biotech	Major Shareholder	Buy	500,000	$5.07	$2,535,000.00	9,579,963
1/19/2023	Target N V Biotech	Major Shareholder	Buy	150,000	$5.30	$795,000.00	9,079,963
12/27/2022	Target N V Biotech	Major Shareholder	Buy	200,000	$5.61	$1,122,000.00	8,929,963
12/23/2022	Target N V Biotech	Major Shareholder	Buy	200,000	$5.88	$1,176,000.00	8,729,963
11/22/2022	Target N V Biotech	Major Shareholder	Buy	300,000	$5.96	$1,788,000.00	8,529,963
10/24/2022	Target N V Biotech	Major Shareholder	Buy	250,000	$4.36	$1,090,000.00	8,229,963
10/21/2022	Target N V Biotech	Major Shareholder	Buy	250,000	$4.63	$1,157,500.00	7,979,963
10/19/2022	Target N V Biotech	Major Shareholder	Buy	168,422	$3.70	$623,161.40	7,443,986
6/15/2022	James Karrels	CFO	Buy	40,000	$2.47	$98,800.00	191,776
11/19/2021	Target N V Biotech	Major Shareholder	Buy	200,000	$18.50	$3,700,000.00
9/28/2021	Target N V Biotech	Major Shareholder	Buy	100,000	$20.64	$2,064,000.00
9/16/2021	Target N V Biotech	Major Shareholder	Buy	400,000	$20.94	$8,376,000.00

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

SEC Filings (Institutional Ownership Changes) for MacroGenics (NASDAQ:MGNX)

96.89% of MacroGenics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

MacroGenics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/16/2024	Frazier Life Sciences Management L.P.	3,010,727	$12.80M	0.6%	+21.8%	4.807%
8/15/2024	Susquehanna Fundamental Investments LLC	129,996	$0.55M	0.0%	+22.9%	0.208%
8/15/2024	Millennium Management LLC	3,312,672	$14.08M	0.0%	+3,473.7%	5.289%
8/15/2024	AQR Capital Management LLC	143,161	$0.61M	0.0%	+74.5%	0.229%
8/15/2024	Armistice Capital LLC	6,000,000	$25.50M	0.3%	+150.0%	9.580%
8/14/2024	K2 Principal Fund L.P.	14,800	$63K	0.0%	N/A	0.024%
8/14/2024	Marshall Wace LLP	658,007	$2.80M	0.0%	+1,689.3%	1.051%
8/14/2024	DRW Securities LLC	13,105	$56K	0.0%	N/A	0.021%
8/14/2024	ProShare Advisors LLC	12,018	$51K	0.0%	-21.4%	0.019%
8/12/2024	Hsbc Holdings PLC	12,103	$50K	0.0%	-27.7%	0.019%
8/9/2024	Renaissance Technologies LLC	484,027	$2.06M	0.0%	-32.3%	0.773%
8/9/2024	Dimensional Fund Advisors LP	898,497	$3.82M	0.0%	-14.5%	1.435%
8/8/2024	Federated Hermes Inc.	300,499	$1.28M	0.0%	-33.8%	0.480%
8/6/2024	Acadian Asset Management LLC	586,079	$2.49M	0.0%	+23.8%	0.936%
8/3/2024	TD Asset Management Inc	169,000	$0.72M	0.0%	-20.8%	0.270%
8/1/2024	Rhumbline Advisers	88,294	$0.38M	0.0%	-5.2%	0.141%
7/30/2024	Pinnacle Associates Ltd.	637,319	$2.71M	0.0%	-1.5%	1.018%
7/29/2024	Principal Financial Group Inc.	348,421	$1.48M	0.0%	+1.1%	0.556%
7/29/2024	Panagora Asset Management Inc.	741,490	$3.15M	0.0%	+60.0%	1.184%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	16,072	$68K	0.0%	+300.6%	0.026%
7/26/2024	Bank of New York Mellon Corp	261,944	$1.11M	0.0%	+4.9%	0.418%
7/16/2024	Diversified Trust Co	18,097	$77K	0.0%	+32.8%	0.029%
5/17/2024	RA Capital Management L.P.	2,082,021	$30.65M	0.4%	-48.6%	3.324%
5/16/2024	California State Teachers Retirement System	47,955	$0.71M	0.0%	+378.7%	0.077%
5/16/2024	Jacobs Levy Equity Management Inc.	148,018	$2.18M	0.0%	+28.7%	0.236%
5/16/2024	Janus Henderson Group PLC	33,403	$0.49M	0.0%	N/A	0.053%
5/15/2024	Bellevue Group AG	9,965,862	$146.70M	2.2%	+0.1%	15.912%
5/15/2024	Price T Rowe Associates Inc. MD	2,438,050	$35.89M	0.0%	+8,361.6%	3.893%
5/15/2024	Avoro Capital Advisors LLC	6,150,000	$90.53M	1.1%	N/A	9.820%
5/14/2024	EntryPoint Capital LLC	2,695	$40K	0.0%	N/A	0.004%
5/14/2024	CANADA LIFE ASSURANCE Co	3,508	$52K	0.0%	N/A	0.006%
5/10/2024	Acadian Asset Management LLC	473,413	$6.97M	0.0%	-55.2%	0.757%
5/10/2024	Vanguard Group Inc.	3,677,678	$54.14M	0.0%	-14.7%	5.879%
5/8/2024	ProShare Advisors LLC	15,282	$0.23M	0.0%	+8.9%	0.024%
5/7/2024	Susquehanna Fundamental Investments LLC	105,787	$1.56M	0.1%	+597.4%	0.169%
5/7/2024	Susquehanna Portfolio Strategies LLC	58,624	$0.86M	0.0%	-60.7%	0.094%
5/7/2024	Swiss National Bank	91,800	$1.35M	0.0%	N/A	0.147%
5/7/2024	ClariVest Asset Management LLC	117,919	$1.74M	0.2%	-36.9%	0.188%
5/1/2024	BNP Paribas Financial Markets	35,313	$0.52M	0.0%	-16.1%	0.056%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	57,060	$0.84M	0.0%	+15.7%	0.091%
4/30/2024	Allspring Global Investments Holdings LLC	12,701	$0.19M	0.0%	-68.9%	0.020%
4/29/2024	Principal Financial Group Inc.	344,603	$5.07M	0.0%	+28.6%	0.551%
4/29/2024	China Universal Asset Management Co. Ltd.	11,935	$0.18M	0.0%	+66.4%	0.019%
4/26/2024	Pinnacle Associates Ltd.	647,235	$9.53M	0.2%	-5.9%	1.035%
4/18/2024	Wasatch Advisors LP	989,579	$14.57M	0.1%	-23.7%	1.582%
4/18/2024	Allspring Global Investments Holdings LLC	12,701	$0.19M	0.0%	-68.9%	0.020%
4/18/2024	Diversified Trust Co	13,630	$0.20M	0.0%	+16.0%	0.022%
4/15/2024	Sound Income Strategies LLC	5,252	$77K	0.0%	N/A	0.008%
4/5/2024	Los Angeles Capital Management LLC	53,113	$0.78M	0.0%	-12.0%	0.085%
3/5/2024	Wellington Management Group LLP	238,123	$2.29M	0.0%	-4.2%	0.384%
2/26/2024	Perceptive Advisors LLC	611,932	$5.89M	0.1%	N/A	0.987%
2/16/2024	Public Employees Retirement System of Ohio	9,144	$88K	0.0%	-24.7%	0.015%
2/15/2024	Frazier Life Sciences Management L.P.	2,401,704	$23.10M	1.2%	+33.2%	3.872%
2/14/2024	Pennant Investors LP	43,800	$0.42M	0.1%	N/A	0.071%
2/14/2024	Wasatch Advisors LP	1,297,574	$12.48M	0.1%	-7.9%	2.092%
2/14/2024	Bellevue Group AG	9,953,313	$95.75M	1.5%	+1.5%	16.046%
2/14/2024	XML Financial LLC	10,600	$0.10M	0.0%	-27.4%	0.017%
2/13/2024	Armistice Capital LLC	4,572,000	$43.98M	0.6%	-3.0%	7.371%
2/13/2024	Campbell & CO Investment Adviser LLC	93,005	$0.90M	0.1%	N/A	0.150%
2/9/2024	Trexquant Investment LP	58,679	$0.56M	0.0%	-64.8%	0.095%
2/9/2024	Dynamic Technology Lab Private Ltd	18,911	$0.18M	0.0%	N/A	0.030%
2/8/2024	Panagora Asset Management Inc.	398,944	$3.84M	0.0%	+5.4%	0.643%
2/8/2024	Massachusetts Financial Services Co. MA	165,107	$1.59M	0.0%	-15.0%	0.266%
2/7/2024	Principal Financial Group Inc.	267,876	$2.58M	0.0%	-2.8%	0.432%
2/7/2024	Jump Financial LLC	14,060	$0.14M	0.0%	N/A	0.023%
2/7/2024	BNP Paribas Financial Markets	42,109	$0.41M	0.0%	+144.5%	0.068%
2/6/2024	Charles Schwab Investment Management Inc.	833,500	$8.02M	0.0%	+1.0%	1.344%
2/6/2024	AJOVista LLC	5,344	$51K	0.1%	N/A	0.009%
2/6/2024	Amalgamated Bank	6,318	$61K	0.0%	-8.9%	0.010%
2/6/2024	Natixis Advisors L.P.	30,892	$0.30M	0.0%	N/A	0.050%
2/5/2024	Russell Investments Group Ltd.	15,342	$0.15M	0.0%	-47.1%	0.025%
1/31/2024	Federated Hermes Inc.	803,375	$7.73M	0.0%	-13.6%	1.295%
1/30/2024	Cornercap Investment Counsel Inc.	29,110	$0.28M	0.0%	-17.6%	0.047%
1/30/2024	Strs Ohio	67,300	$0.65M	0.0%	-40.1%	0.108%
1/25/2024	Allspring Global Investments Holdings LLC	40,834	$0.39M	0.0%	+64.4%	0.066%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	49,337	$0.48M	0.0%	+7.2%	0.080%
1/24/2024	China Universal Asset Management Co. Ltd.	7,174	$69K	0.0%	+349.2%	0.012%
1/19/2024	Pinnacle Associates Ltd.	687,980	$6.62M	0.1%	-1.3%	1.109%
1/12/2024	SG Americas Securities LLC	28,589	$0.28M	0.0%	+36.9%	0.046%
1/5/2024	Exchange Traded Concepts LLC	30,085	$0.29M	0.0%	+34.0%	0.049%
12/18/2023	Vanguard Group Inc.	4,414,924	$20.57M	0.0%	+0.8%	7.118%
12/1/2023	Wellington Management Group LLP	248,520	$1.16M	0.0%	+3.0%	0.401%
11/15/2023	RA Capital Management L.P.	342,000	$1.59M	0.0%	N/A	0.551%
11/15/2023	GSA Capital Partners LLP	225,918	$1.05M	0.1%	+74.9%	0.364%
11/15/2023	Rock Springs Capital Management LP	1,178,796	$5.49M	0.1%	+5.0%	1.900%
11/15/2023	Sectoral Asset Management Inc.	387,001	$1.80M	0.4%	+9.8%	0.624%
11/15/2023	Armistice Capital LLC	4,712,000	$21.96M	0.3%	-15.9%	7.596%
11/14/2023	Corton Capital Inc.	16,876	$79K	0.0%	-77.1%	0.027%
11/14/2023	Sherbrooke Park Advisers LLC	21,219	$99K	0.0%	N/A	0.034%
11/14/2023	Trexquant Investment LP	166,689	$0.78M	0.0%	-4.8%	0.269%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	139,251	$0.65M	0.0%	N/A	0.224%
11/13/2023	Federated Hermes Inc.	930,076	$4.33M	0.0%	-1.2%	1.499%
11/13/2023	Acadian Asset Management LLC	1,371,396	$6.39M	0.0%	+7.8%	2.211%
11/13/2023	Silverarc Capital Management LLC	1,264,158	$5.89M	1.8%	+4.0%	2.038%
11/13/2023	WINTON GROUP Ltd	31,647	$0.15M	0.0%	N/A	0.051%
11/8/2023	Massachusetts Financial Services Co. MA	194,204	$0.91M	0.0%	+32.9%	0.313%
11/7/2023	Barclays PLC	134,273	$0.62M	0.0%	+15.2%	0.217%
11/6/2023	Los Angeles Capital Management LLC	60,329	$0.28M	0.0%	N/A	0.097%
11/2/2023	Principal Financial Group Inc.	275,550	$1.28M	0.0%	+0.9%	0.445%
10/31/2023	Panagora Asset Management Inc.	378,660	$1.77M	0.0%	-1.3%	0.611%

Data available starting January 2016

MacroGenics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 × CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. In addition, it develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3; Retifanlimab, a humanized monoclonal antibody targeting programmed death receptor-1; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company develops MGD014 and MGD020, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and CD3 on T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. It has collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.

Today's Range

Now: $3.43

$3.33

$3.79

50 Day Range

MA: $4.00

$3.23

$5.55

52 Week Range

Now: $3.43

$3.14

$21.88

Volume

724,307 shs

Average Volume

1,666,866 shs

Market Capitalization

$214.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.09

Who are the company insiders with the largest holdings of MacroGenics?: MacroGenics' top insider shareholders include:
Target N V Biotech (Major Shareholder)
Ezio Bonvini (SVP)
Edward Hurwitz (Director)
Jeffrey Stuart Peters (VP)
Learn More about top insider investors at MacroGenics.
Who are the major institutional investors of MacroGenics?: MacroGenics' top institutional investors include:
Armistice Capital LLC — 9.58%
Millennium Management LLC — 5.29%
Frazier Life Sciences Management L.P. — 4.81%
Dimensional Fund Advisors LP — 1.43%
Panagora Asset Management Inc. — 1.18%
Marshall Wace LLP — 1.05%
Learn More about top institutional investors of MacroGenics stock.
Which major investors are selling MacroGenics stock?: During the last quarter, MGNX stock was sold by these institutional investors:
Renaissance Technologies LLC
Federated Hermes Inc.
Dimensional Fund Advisors LP
TD Asset Management Inc
Pinnacle Associates Ltd.
Rhumbline Advisers
Hsbc Holdings PLC
ProShare Advisors LLC
In the previous year, company insiders that have sold MacroGenics company stock include:
Target N V Biotech (Major Shareholder)
Ezio Bonvini (SVP)
Learn More investors selling MacroGenics stock.
Which major investors are buying MacroGenics stock?: During the previous quarter, MGNX stock was purchased by institutional investors including:
Armistice Capital LLC
Millennium Management LLC
Marshall Wace LLP
Frazier Life Sciences Management L.P.
Panagora Asset Management Inc.
Acadian Asset Management LLC
AQR Capital Management LLC
Susquehanna Fundamental Investments LLC
Within the previous year, these company insiders have bought MacroGenics stock:
Target N V Biotech (Major Shareholder)
Ezio Bonvini (SVP)
Learn More investors buying MacroGenics stock.